HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hironori Nishitsuji Selected Research

Hepatitis B virus P protein

1/2018TIP60 Complex Inhibits Hepatitis B Virus Transcription.
1/2017Identification of KX2-391 as an inhibitor of HBV transcription by a recombinant HBV-based screening assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hironori Nishitsuji Research Topics

Disease

19Infections
01/2022 - 01/2004
4Virus Diseases (Viral Diseases)
01/2022 - 07/2013
3Chronic Hepatitis B
01/2022 - 01/2017
3Hepatitis B
01/2022 - 01/2020
3Hepatocellular Carcinoma (Hepatoma)
12/2019 - 09/2014
2Inflammation (Inflammations)
09/2014 - 07/2013
1Viremia
01/2022
1Severe Acute Respiratory Syndrome
01/2021
1Hepatitis
01/2021
1Bites and Stings (Sting)
12/2019
1Hepatitis C
09/2018
1Hyperplasia
09/2014
1Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2010
1T-Cell Leukemia (Leukemia, T Cell)
05/2009
1Osteonecrosis (Kienbock's Disease)
01/2009

Drug/Important Bio-Agent (IBA)

6Antiviral Agents (Antivirals)IBA
01/2022 - 01/2016
5sodium-bile acid cotransporterIBA
12/2020 - 11/2015
5Small Interfering RNA (siRNA)IBA
01/2018 - 01/2004
4RNA (Ribonucleic Acid)IBA
01/2021 - 09/2014
4Proteins (Proteins, Gene)FDA Link
03/2020 - 06/2006
3Circular DNAIBA
01/2021 - 01/2016
3Complementary DNA (cDNA)IBA
06/2006 - 01/2004
2Amino AcidsFDA Link
01/2022 - 01/2021
2Monoclonal AntibodiesIBA
01/2022 - 12/2020
2Hepatitis B e AntigensIBA
01/2021 - 07/2018
2DNA (Deoxyribonucleic Acid)IBA
07/2018 - 09/2014
2Hepatitis B virus P proteinIBA
01/2018 - 01/2017
2Messenger RNA (mRNA)IBA
01/2017 - 07/2013
2nanolucIBA
01/2017 - 11/2015
2IntegrasesIBA
11/2009 - 11/2004
1Immunoglobulin G (IgG)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Bile Acids and Salts (Bile Acids)IBA
01/2022
1myrcludex-BIBA
01/2022
1Leucine (L-Leucine)FDA Link
01/2021
1OzoneIBA
01/2021
1Isoleucine (L-Isoleucine)FDA Link
01/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2021
1EpitopesIBA
12/2020
1ErbB Receptors (EGF Receptor)IBA
01/2020
1Epidermal Growth Factor (EGF)IBA
01/2020
1A-factor (Streptomyces)IBA
12/2019
1Antimalarials (Antimalarial Agents)IBA
09/2018
1Pharmaceutical PreparationsIBA
09/2018
1AntigensIBA
07/2018
1Hepatitis B Surface Antigens (HBsAg)FDA Link
07/2018
1Alanine Transaminase (SGPT)IBA
07/2018
1InterferonsIBA
07/2018
1glabridinIBA
05/2018
1src-Family KinasesIBA
01/2017
1Interferon-alpha (Interferon Alfa)IBA
01/2017
1tirbanibulinIBA
01/2017
1Long Noncoding RNAIBA
01/2016
1Conditioned Culture MediaIBA
07/2013
1CytokinesIBA
07/2013
1ChemokinesIBA
07/2013
1CCAAT-Enhancer-Binding ProteinsIBA
07/2013
1Pattern Recognition ReceptorsIBA
11/2010
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2010
1Toll-Like Receptor 3IBA
11/2010
1Viral RNAIBA
11/2009
1Interferon Type IIBA
05/2009
1SteroidsIBA
01/2009

Therapy/Procedure

3Therapeutics
07/2018 - 01/2016
1Immunotherapy
03/2020